GAM
UTHR icon

Gotham Asset Management’s United Therapeutics UTHR Stock Holding History

Gotham Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.7M Buy
80,387
+369
+0.5% +$184K 0.15% 128
2025
Q4 		$39M Sell
80,018
-939
-1% -$437K 0.14% 131
2025
Q3 		$33.9M Sell
80,957
-8,446
-9% -$2.84M 0.15% 124
2025
Q2 		$25.7M Buy
89,403
+61
+0.1% +$18.2K 0.15% 112
2025
Q1 		$27.5M Buy
89,342
+28,163
+46% +$9.65M 0.23% 31
2024
Q4 		$21.6M Buy
61,179
+9,121
+18% +$3.35M 0.2% 65
2024
Q3 		$18.7M Buy
52,058
+4,465
+9% +$1.51M 0.19% 77
2024
Q2 		$15.2M Buy
47,593
+1,524
+3% +$403K 0.2% 65
2024
Q1 		$10.6M Buy
46,069
+19,863
+76% +$4.48M 0.16% 128
2023
Q4 		$5.76M Sell
26,206
-755
-3% -$174K 0.11% 242
2023
Q3 		$6.09M Sell
26,961
-1,300
-5% -$299K 0.13% 196
2023
Q2 		$6.24M Sell
28,261
-94
-0.3% -$20.8K 0.14% 167
2023
Q1 		$6.35M Buy
28,355
+18,045
+175% +$4.45M 0.15% 139
2022
Q4 		$2.87M Sell
10,310
-2,236
-18% -$564K 0.08% 311
2022
Q3 		$2.63M Buy
12,546
+3,469
+38% +$776K 0.08% 307
2022
Q2 		$2.14M Buy
9,077
+1,688
+23% +$343K 0.07% 350
2022
Q1 		$1.33M Sell
7,389
-1,676
-18% -$319K 0.04% 476
2021
Q4 		$1.96M Sell
9,065
-4,054
-31% -$796K 0.06% 348
2021
Q3 		$2.42M Buy
13,119
+3,009
+30% +$593K 0.1% 267
2021
Q2 		$1.81M Sell
10,110
-9,054
-47% -$1.72M 0.08% 337
2021
Q1 		$3.21M Buy
19,164
+7,546
+65% +$1.26M 0.14% 210
2020
Q4 		$1.76M Sell
11,618
-17,130
-60% -$2.25M 0.06% 383
2020
Q3 		$2.9M Sell
28,748
-5,270
-15% -$578K 0.09% 282
2020
Q2 		$4.12M Buy
34,018
+4,458
+15% +$502K 0.12% 219
2020
Q1 		$2.8M Sell
29,560
-39,631
-57% -$3.77M 0.08% 336
2019
Q4 		$6.09M Buy
69,191
+21,574
+45% +$1.9M 0.11% 245
2019
Q3 		$3.8M Sell
47,617
-596
-1% -$48K 0.07% 330
2019
Q2 		$3.76M Buy
48,213
+35,858
+290% +$3.35M 0.06% 368
2019
Q1 		$1.45M Sell
12,355
-18,572
-60% -$2.16M 0.02% 559
2018
Q4 		$3.37M Sell
30,927
-4,081
-12% -$473K 0.05% 402
2018
Q3 		$4.48M Sell
35,008
-32,233
-48% -$3.99M 0.06% 369
2018
Q2 		$7.61M Sell
67,241
-14,519
-18% -$1.6M 0.11% 262
2018
Q1 		$9.19M Buy
81,760
+15,490
+23% +$1.97M 0.13% 241
2017
Q4 		$9.8M Sell
66,270
-114,915
-63% -$14.6M 0.14% 219
2017
Q3 		$21.2M Sell
181,185
-12,805
-7% -$1.64M 0.31% 84
2017
Q2 		$25.2M Sell
193,990
-15,150
-7% -$1.89M 0.35% 80
2017
Q1 		$28.3M Buy
209,140
+43,115
+26% +$6.53M 0.36% 69
2016
Q4 		$23.8M Sell
166,025
-151,333
-48% -$19.3M 0.31% 100
2016
Q3 		$37.5M Sell
317,358
-49,717
-14% -$5.97M 0.49% 41
2016
Q2 		$38.9M Buy
367,075
+4,510
+1% +$503K 0.47% 40
2016
Q1 		$40.4M Buy
362,565
+34,255
+10% +$4.33M 0.45% 36
2015
Q4 		$51.4M Buy
328,310
+27,105
+9% +$3.95M 0.56% 28
2015
Q3 		$39.5M Buy
301,205
+40,080
+15% +$6.43M 0.39% 70
2015
Q2 		$45.4M Sell
261,125
-29,952
-10% -$5.39M 0.38% 73
2015
Q1 		$50.2M Sell
291,077
-32,011
-10% -$4.88M 0.38% 84
2014
Q4 		$41.8M Buy
323,088
+34,687
+12% +$4.47M 0.34% 101
2014
Q3 		$37.1M Sell
288,401
-357,665
-55% -$36.9M 0.37% 78
2014
Q2 		$57.2M Buy
646,066
+329,577
+104% +$31.7M 0.72% 4
2014
Q1 		$29.8M Buy
316,489
+121,894
+63% +$12.5M 0.45% 43
2013
Q4 		$22M Sell
194,595
-177,552
-48% -$16M 0.52% 11
2013
Q3 		$29.3M Buy
372,147
+30,817
+9% +$2.25M 0.95% 2
2013
Q2 		$22.5M Buy
+341,330
New +$22M 0.96% 3

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Gotham Asset Management's UTHR Position: Q1 2026 in Review

Gotham Asset Management increased its United Therapeutics (UTHR) stake by 0.46% in Q1 2026, buying an estimated $184K and bringing the position to 80,387 shares worth $47.7M. The position accounts for 0.15% of the portfolio, ranked #128.

Gotham Asset Management first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.2M in Q2 2014. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Gotham Asset Management held 80,387 shares of United Therapeutics worth $47.7M as of Q1 2026.
  • Gotham Asset Management bought 369 United Therapeutics shares in Q1 2026, an estimated $184K.
  • United Therapeutics made up 0.15% of Gotham Asset Management's portfolio in Q1 2026, its #128 holding.
  • Gotham Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Gotham Asset Management's United Therapeutics position peaked at $57.2M in Q2 2014.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.